Literature DB >> 20511642

'Fatal 2,4-dinitrophenol poisoning... coming to a hospital near you'.

Claas Siegmueller1, Raghunanda Narasimhaiah.   

Abstract

An adult man was brought into the emergency department after deliberate ingestion of dinitrophenol: an agent that uncouples mitochondrial oxidative phosphorylation. The patient rapidly developed a hyper-metabolic state with fever, respiratory failure and died within a few hours after admission. Dinitrophenol is used in the manufacture of dyes, pesticides and explosives. Sub-acute poisoning is associated with weight-loss and the substance had been prescribed for this purpose during the 1930s in the United States before being banned due to serious side effects. Although remaining unlicensed as a drug, dinitrophenol is widely available through mail-order websites and online pharmacies, which promote it as an anti-obesity treatment. This case highlights the need for awareness of possibly increasing rates of accidental poisoning with a growing obesity prevalence and availability of this unlicensed drug through the internet. Additionally, we discuss the use of dantrolene in dinitrophenol poisoning and question whether current Toxbase/UK National Poison Information Service treatment guidelines regarding the indication and dosing of this drug, the only relatively specific treatment in dinitrophenol poisoning presently recommended, could be revised.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20511642     DOI: 10.1136/emj.2009.072892

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  9 in total

1.  Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.

Authors:  Leigh Goedeke; Rachel J Perry; Gerald I Shulman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

2.  Dantrolene is not the answer to 2,4-dinitrophenol poisoning: more heated debate.

Authors:  Jason Van Schoor; Esha Khanderia; Andrew Thorniley
Journal:  BMJ Case Rep       Date:  2018-12-19

3.  Death within 44 days of 2,4-dinitrophenol intake.

Authors:  Fred Zack; Verena Blaas; Christoph Goos; Daniel Rentsch; Andreas Büttner
Journal:  Int J Legal Med       Date:  2016-05-11       Impact factor: 2.686

Review 4.  2,4-dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death.

Authors:  Johann Grundlingh; Paul I Dargan; Marwa El-Zanfaly; David M Wood
Journal:  J Med Toxicol       Date:  2011-09

Review 5.  Toxicity of weight loss agents.

Authors:  May Yen; Michele Burns Ewald
Journal:  J Med Toxicol       Date:  2012-06

Review 6.  Diet aid or aid to die: an update on 2,4-dinitrophenol (2,4-DNP) use as a weight-loss product.

Authors:  Daniela Sousa; Helena Carmo; Rita Roque Bravo; Félix Carvalho; Maria de Lourdes Bastos; Paula Guedes de Pinho; Diana Dias da Silva
Journal:  Arch Toxicol       Date:  2020-02-20       Impact factor: 5.153

7.  Beware the yellow slimming pill: fatal 2,4-dinitrophenol overdose.

Authors:  Alexander Holborow; Richard M Purnell; Jenny Frederina Wong
Journal:  BMJ Case Rep       Date:  2016-04-04

Review 8.  Endocrine disrupting chemicals: Friend or foe to brown and beige adipose tissue?

Authors:  Cynthia E Francis; Logan Allee; Helen Nguyen; Rachel D Grindstaff; Colette N Miller; Srujana Rayalam
Journal:  Toxicology       Date:  2021-10-02       Impact factor: 4.571

9.  Intravenous dantrolene in hypermetabolic syndromes: a survey of the U.S. Veterans Health Administration database.

Authors:  Stanley N Caroff; Christopher B Roberts; Henry Rosenberg; Joseph R Tobin; Stacey Watt; Darlene Mashman; Sheila Riazi; Rosalind M Berkowitz
Journal:  BMC Anesthesiol       Date:  2022-09-19       Impact factor: 2.376

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.